Selective depletion of DNMT1 was reported to reactivate expression of CDKN2A/p16 in HCT116 colon cancer cells and re-expression of CDKN2A/p16 after knockdown of DNMT1 in human lung and breast cancer cells (74,76,78). The gene discussed is CDKN2A; the disease is breast carcinoma.